UnitedHealth Group (UNH) - Enterprise Value to EBITDA Ratio

UnitedHealth Group Inc. - graphic logo of issuer UNH

UnitedHealth Group (UNH) dominates the health insurance sector through vertical integration while maintaining a minimal carbon footprint via digitalization. The EV/EBITDA multiple in a historical context allows for the tracking of excessive leverage risks, where 0.00 reflects the baseline level of the metric. Growth prospects are based on an aging population and the development of Optum analytics to optimize costs.

UNH UnitedHealthcare: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/11/2026

Analytical breakdowns for unitedhealthgroup.com (UNH)

- current price and projected stock value:
Stock Price UnitedHealth Group Incorporated|UNH - Fair Value Consensus
- market capitalization indicators:
Market Valuation UnitedHealth Group Inc.|UNH - Enterprise Value
- business book valuation details:
Net Assets per Single Share UnitedHealth Group|UNH - Accounting Capitalization|Market Capitalization to Book Value Ratio unitedhealthgroup.com|UNH - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio UnitedHealth Group|UNH - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital UnitedHealth|UNH - Company Cumulative Debt|Debts to Book Capitalization UnitedHealth Group Inc.|UNH - Company Long-Term Indebtedness|Company Short-Term Debts UnitedHealth Group|Quick Ratio unitedhealthgroup.com
- business earnings and investment ratios data:
UNH - Company Net Income|Projected Future Earnings UnitedHealth Group|UNH - P/E Multiple|Future Price to Earnings UnitedHealth Group|UNH - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio UnitedHealth Group Inc.|UNH - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) UnitedHealth Group|UNH - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months unitedhealthgroup.com|UNH - Earnings per share increase in current year|Earnings growth forecast for next year UnitedHealth Group
Initial company analysis:UnitedHealth Group Incorporated UNH
Manufactured products of unitedhealthgroup.com

Investors are evaluating UnitedHealth Group (UNH) through the lens of cash flow resilience to market shocks. The multiple compares the total enterprise value, including debt, with operating profit before taxes, depreciation, and amortization, neutralizing the impact of the financing structure. By analyzing the dynamic EV/EBITDA value of UnitedHealth Group (UNH), one can determine the extent of the asset's overvaluation relative to its ability to act as a cash generator. For the non-cyclical healthcare sector, low indicator values confirm high investment attractiveness.

Competitor analysis for UnitedHealth Group

EV/EBITDA Multiple CI (Cigna Corporation)|Business Value to Operating Income Before Depreciation AFL|HUM: Enterprise Value to EBITDA Ratio|CNC - EV/EBITDA Multiple|Molina Healthcare (MOH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MMS|OSCR (Oscar Health Inc) - EV/EBITDA Multiple|Clover Health Inc (CLOV) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio CTEV (Claritev Corp)|Enterprise Value to Operating Income Before Depreciation Ratio YB|EV/EBITDA Multiple HIT (Health In Tech)|eHealth Inc. (EHTH) - Company Value to EBITDA|GoHealth.com - EV/EBITDA Multiple|NEUE (NeueHealth, Inc.) - Enterprise Value to Operating Income Before Depreciation|RELI: EV/EBITDA Multiple|msprecovery.com - Business Value to Operating Income Before Depreciation|MPLN (MultiPlan) - EV/EBITDA Multiple